Technical Analysis | Spotlight
RhoVac — Stopping metastasis in its tracks - Edison Group
FUTURE ANTI-CANCER DRUGS
RhoVac reports positive written response from the FDA regarding recently completed pre-IND meeting
RhoVac AB will be transferred to Spotlight Stock Market's observation list
RhoVac AB conducts conditional reverse takeover of Chosa ApS
RhoVac – Stora Aktiedagen Stockholm 30 november 2021 - YouTube
Rhovac køber danske Chosa — MedWatch
Chosa Oncology — Making headway in precision oncology - Edison Group
Rhovac – Revolutionerar immunologisk cancerbehandling | Redeye
Market Notice 36/23 – RhoVac AB changes name to CHOSA Oncology AB
First patient in treatment in RhoVac's clinical phase IIb study in the USA
RhoVac — Stopping metastasis in its tracks - Edison Group
RhoVac retains international investment bank as advisor for desired RV001 transaction
Technical Analysis | Spotlight
Chosa ApS completed the acquisition of RhoVac AB from M2 Asset Management AB and others in a reverse merger transaction. -January 17, 2023 | MarketScreener
Nyemission Chosa Oncology AB på - Aktier
Inbjudan till att teckna konvertibler i RhoVac AB (publ) Teckningsperiod 17–31 mars 2022
Global Covid-19 Vaccination Roll-out causes delay to RhoVac's Phase IIb study
Chosa ApS completed the acquisition of RhoVac AB from M2 Asset Management AB and others in a reverse merger transaction. -January 17, 2023 | MarketScreener
Rhovac-aktionærer godkender køb af danske Chosa — MedWatch
